Eurobio Scientific SA

Paris Stock Exchange ALERS.PA

Eurobio Scientific SA Return on Capital Employed (ROCE) for the year ending December 31, 2023: 3.91%

Eurobio Scientific SA Return on Capital Employed (ROCE) is 3.91% for the year ending December 31, 2023, a -65.54% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Eurobio Scientific SA Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 11.34%, a -72.64% change year over year.
  • Eurobio Scientific SA Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 41.46%, a -36.81% change year over year.
  • Eurobio Scientific SA Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 65.60%, a 1,522.79% change year over year.
  • Eurobio Scientific SA Return on Capital Employed (ROCE) for the year ending December 31, 2019 was -4.61%, a 54.11% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
SV Wall Street
Paris Stock Exchange: ALERS.PA

Eurobio Scientific SA

CEO Mr. Denis Fortier
IPO Date Nov. 18, 2005
Location France
Headquarters 7 avenue de Scandinavie
Employees 329
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.

Similar companies

ALBIO.PA

Biosynex SA

USD 1.31

15.27%

StockViz Staff

January 31, 2025

Any question? Send us an email